Please login to the form below

Not currently logged in
Email:
Password:

IPG Mediabrands creates healthcare agency

New global life sciences division Healix launched in the US

IPG MediabrandsInternational media agency group IPG Mediabrands has launched a new healthcare offering focused exclusively on life science and healthcare brands.

Based in New York with affiliates across the EMEA and Asia-Pacific regions, the new agency - called Healix - will provide pharmaceutical, biotech and healthcare clients with media planning strategies created using innovative data analytics tools.

Henry Tajer, global chief executive of IPG Mediabrands, said: “Healix is an evolution of our best-in-class services.

“The dynamic talent working at Healix is wholly committed to creating better business outcomes for healthcare brands, backed by our network's expertise across media intelligence and innovation.”

Jeffrey Erb will lead the new venture as president of its North American operations, joining the agency group from Alliance Life Sciences where he served as its senior vice president and managing director.

Erb commented: “I'm very excited to be part of the IPG Mediabrands team and its innovative approach to media.

“The creation of a media company completely dedicated to healthcare demonstrates IPG Mediabrands' commitment to providing its clients with the highest caliber of service specific to their market.

“I'm thrilled to be leading that charge.”

Article by
Rebecca Clifford

10th October 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics